These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 10919107)

  • 1. Adverse drug reactions to fluoroquinolones in pediatric patients in a tertiary care hospital.
    Reeta K; Uppal R; Jhaj R; Malhotra S; Bhargava VK
    Indian J Physiol Pharmacol; 2000 Jan; 44(1):113-4. PubMed ID: 10919107
    [No Abstract]   [Full Text] [Related]  

  • 2. Adverse effects prompt withdrawal of temafloxacin.
    Clin Pharm; 1992 Sep; 11(9):747, 750. PubMed ID: 1325891
    [No Abstract]   [Full Text] [Related]  

  • 3. [Levofloxacin adverse effects, data from clinical trials and pharmacovigilance].
    Carbon C
    Therapie; 2001; 56(1):35-40. PubMed ID: 11322015
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Safety of fluoroquinolones 10 years later].
    Frías Iniesta J; Ibáñez Ruiz C; Esteban Calvo C
    Rev Esp Quimioter; 1999 Mar; 12(1):34-40. PubMed ID: 10209062
    [No Abstract]   [Full Text] [Related]  

  • 5. Serious liver injury. Leading reason for drug removals, restrictions.
    Meadows M
    FDA Consum; 2001; 35(3):8-9. PubMed ID: 11458559
    [No Abstract]   [Full Text] [Related]  

  • 6. Adverse effects of fluoroquinolones.
    Shimada J; Hori S
    Prog Drug Res; 1992; 38():133-43. PubMed ID: 1609111
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The safety profile of the fluoroquinolones.
    Bertino J; Fish D
    Clin Ther; 2000 Jul; 22(7):798-817; discussion 797. PubMed ID: 10945507
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fluoroquinolone-associated dysglycemias: a tale of two toxicities.
    Owens RC
    Pharmacotherapy; 2005 Oct; 25(10):1291-5. PubMed ID: 16185171
    [No Abstract]   [Full Text] [Related]  

  • 9. Fluoroquinolones. Adverse reactions during clinical trials and postmarketing surveillance.
    Janknegt R
    Pharm Weekbl Sci; 1989 Aug; 11(4):124-7. PubMed ID: 2677983
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adverse drug reactions: implications for the development of fluoroquinolones.
    Ball P
    J Antimicrob Chemother; 2003 May; 51 Suppl 1():21-7. PubMed ID: 12702700
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antimicrobial safety and tolerability: differences and dilemmas.
    Mandell LA; Ball P; Tillotson G
    Clin Infect Dis; 2001 Mar; 32 Suppl 1():S72-9. PubMed ID: 11249832
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fluoroquinolone AUIC break points and the link to bacterial killing rates: in vitro models.
    Zhanel GG; Noreddin AM
    Ann Pharmacother; 2003 Sep; 37(9):1331-4. PubMed ID: 12921519
    [No Abstract]   [Full Text] [Related]  

  • 13. Adverse drug reactions among children over a 10-year period.
    Le J; Nguyen T; Law AV; Hodding J
    Pediatrics; 2006 Aug; 118(2):555-62. PubMed ID: 16882807
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-infectives-induced adverse drug reactions in hospitalized patients.
    Gholami K; Parsa S; Shalviri G; Sharifzadeh M; Assasi N
    Pharmacoepidemiol Drug Saf; 2005 Jul; 14(7):501-6. PubMed ID: 15844215
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Tendinopathies and fluoroquinolones: a public health problem? Value of drug monitoring studies].
    Pierfitte C
    Bull Soc Sci Med Grand Duche Luxemb; 1995; 132(3):39-40. PubMed ID: 8665625
    [No Abstract]   [Full Text] [Related]  

  • 16. Sulfonamide allergies and outcomes related to use of potentially cross-reactive drugs in hospitalized patients.
    Hemstreet BA; Page RL
    Pharmacotherapy; 2006 Apr; 26(4):551-7. PubMed ID: 16553515
    [TBL] [Abstract][Full Text] [Related]  

  • 17. From the Food and Drug Administration.
    Nightingale SL
    JAMA; 1999 Jul; 282(1):19. PubMed ID: 10404896
    [No Abstract]   [Full Text] [Related]  

  • 18. Fluoroquinolones and their adverse effects.
    Girdhar BK
    Indian J Lepr; 1993; 65(1):69-79. PubMed ID: 8463726
    [No Abstract]   [Full Text] [Related]  

  • 19. An updated safety profile of moxifloxacin.
    Iannini PB; Mandell LA
    J Chemother; 2002 Feb; 14 Suppl 2():29-34. PubMed ID: 12003138
    [No Abstract]   [Full Text] [Related]  

  • 20. Clinical perspectives on new antimicrobials: focus on fluoroquinolones.
    Talan DA
    Clin Infect Dis; 2001 Mar; 32 Suppl 1():S64-71. PubMed ID: 11249831
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.